Previous 10 | Next 10 |
Organon has shown disappointing share price performance since being spun-off from Merck. However, its business fundamentals are solid, with Women's Health and Biosimilars segments showing promising growth. I highlight why Organon is a solid value Buy at the moment for income and g...
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference on Monday, September 13, 2021 at 9:30 a.m...
Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Citi’s 16th Annual BioPharma Virtual Conference on Friday, September 10, 2021 at 9:45 a.m. EDT. Investo...
Merck continues to attract me for a long-term investment. The company has seen an eventful year, notably with the spinoff of Organon. Pro forma multiples have risen a bit following the spinoff as growth outside Keytruda would be very much welcome here. Despite non-Keytruda gro...
The S&P 500 is potentially on track for the greatest year in market history and is 30% historically overvalued. But for those with the right watchlists and tools, Buffett-style "fat pitch" deals are always available. Today Amazon, Bristol Myers, Organon, and BorgWarner represe...
Berkshire Hathaway's 13F stock portfolio value increased from $270.44B to $293.02B this quarter. Their largest three holdings are at ~64% of the entire portfolio. Berkshire Hathaway increased Kroger while reducing Merck and Liberty Global during the quarter. For further deta...
On its Q2 earnings report, Organon hit all the milestones needed to move the stock out of its post-spin doldrums. Data given this quarter should alleviate bear concerns around leverage, revenue declines, growth strategy, dividend, and FCF. With P/E and P/FCF multiples at 5-6x, EV/...
Benjamin Graham is known for developing a fairly complex set of rules and formulas to determine a stock’s intrinsic value. In his final year, Graham offered a much simpler means of finding value, but these simple value comparison tools are often overlooked by many investors. ...
Organon & Co (OGN) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Jennifer Halchak – Vice President of Investor Relations Kevin Ali – Chief Executive Officer Matt Walsh – Chief Financial Officer Conference Call Participants Terence Fl...
The following slide deck was published by Organon & Co. in conjunction with their 2021 Q2 earnings call. For further details see: Organon & Co. 2021 Q2 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VANCOUVER, BC / ACCESSWIRE / July 31, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce a new significant gold-silver discovery, called the Navidad vein system, on the Ermitaño Mine concessions in Sonora, Mexico where the Company holds a...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...